For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques while ...
Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...
For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques ...
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the appointment of Jessica Chutter to its Board of Directors. Ms. Chutter is a highly accomplished biotechnology investment banker with an ...
The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.
GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk In a phase 2 trial in Chinese ...
UH President Renu Khator wants to expand the school's suburban footprint. To do it, she'll need millions from donors or state ...
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production ...
A grand jury in Dayton, Ohio, returned charges against six Chinese nationals and two Chinese pharmaceutical companies in ...
OG Acquisition 2 Corp. (“OG” or the “Company”) is pleased to provide an update on its previously announced business ...
Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results